(Date:12/10/2009)... division of the National Institutes of Health (NIH), awarded a ... development of a non-invasive, passive diffusion-based treatment for severe, non-infectious ... ... Lake City, UT (PRWEB) December 10, 2009 -- The National ... Health (NIH), awarded a $2.18 million grant to Aciont Inc. ...
(Date:12/10/2009)... -- Newly published research, by investigators, at ... (NESCI) in the journal STEM CELLS reported ... with "Limbal Stem Cell Deficiency" (LSCD) using ... need of suppressing their immunity. ,, ... a painful, blinding disease that requires long-term, ...
(Date:12/10/2009)... a world-leading provider of advanced flow measurement, control, ... join the company as Global Level Product Manager ... Instrument’s efforts to enhance market penetration of the ... joining Brooks Instrument from Lafarge Corp, a manufacturer ... of Marketing and Sales. Bayda will report to ...
(Date:12/10/2009)... CORALVILLE, Iowa, Dec. 10 Vivakor, ... that it has entered into an exclusive, ... specialist, Regeneca International, Inc. ( www.regeneca.com ). ... distribution rights to a new cutting-edge nutraceutical ... the development of future formulations by Vivakor ...
Breaking Biology Technology:NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3Successful Stem Cell Therapy for Treatment of Eye Disease 2Successful Stem Cell Therapy for Treatment of Eye Disease 3Successful Stem Cell Therapy for Treatment of Eye Disease 4Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3... Trial Experience and Business Development Leadership ... Mass., Jan. 16 Cytel, Inc. announced today,that ... has,accepted the role of Vice President of Cytel ... of management experience guiding drug,biologic and medical device ...
... Jan. 16 /PRNewswire-FirstCall/ - Helix BioPharma Corp.,(TSX: HBP/Frankfurt: ... an,agreement with KBI Biopharma Inc. ("KBI") to develop ... powder) vial format,suitable for clinical testing., "This ... objective of,initiating clinical testing with L-DOS47," said John ...
... M.D. Clarifies Previous Statement on 1/11/08, SPOKANE, Wash., ... the issue regarding the use of estriol in compounded ... estriol in her medical practice. Cheryle Hart, M.D.,is Mayo ... what is,now Hormones by Hart in 1997. She is ...
Other Biology Technology:Irving Dark Named Vice President of Cytel Clinical Research Services 2Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format 2Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format 3Bio-Identical Hormone Menopause Doctor Responds to Recent FDA News About Estriol 2Mouse monoclonal [3G8] to MDMA ( Abpromise for all tested applications)....
Shh Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Anti-Cohesin (Scc1/Rad21) Monoclonal Antibody Research Focus: signal transduction Storage: -20C Shipping Temperature: +4C...
... Rabbit monoclonal [EP282Y] to ... for all tested applications). ... peptide corresponding to residues in ... synthetase. Entrez ...
Biology Products:Biology NavigationMedical Navigation